Greystar buys Greenford site for giant PRS scheme

Wednesday, January 27, 2016 | Paul Norman

Greystar Europe Holdings has bought, with an institutional partner, the 26.5 acre site former GlaxoSmithKline site in Greenford, West London for a major purpose built rental housing led scheme.


The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.

Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.

The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.

Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.

For entire article, click View More below.
 
Media Resources
View our PRESS KIT
Press Release Archives
  • Tuesday, September 14, 2021
    Greystar acquires a build to rent asset in Madrid with 455 apartments

    Read More

  • Monday, September 13, 2021
    Greystar and Fender Katsalidis announce approval of Australia’s largest build-to-rent development

    Read More

  • Tuesday, September 7, 2021
    Ivanhoé Cambridge, Bouwinvest and Greystar agree to acquire first asset for Paris student and young professional accommodation venture

    Read More

  • Wednesday, August 11, 2021
    Sacramento State, Greystar Celebrate the Opening of Hornet Commons

    Read More

  • Thursday, July 29, 2021
    Greystar hires Jeff Cangemi as Managing Director of University Partnerships to support expansion of platform

    Read More

View All Archives